Product Program year 2019 Source: CMS Open Payments

Hyperlipidemia - Disease

Drug

Open in the dashboard

General payments

$5,934

123 payments

Research payments

$0

0 payments

Through program year 2019, $5,934 in general payments and $0 in research payments were reported against Hyperlipidemia - Disease.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $5,934 123

Breakdown

Who paid General payments · program year 2019
  1. Sanofi-Aventis U.S. LLC $5,934 123 payments
Top recipients General payments · program year 2019
  1. Albert Lopez Internal Medicine · Jacksonville, FL $302 5% · 5 payments
  2. Bashab Banerji Internal Medicine · Las Vegas, NV $216 4% · 3 payments
  3. Kari Uusinarkaus Family Medicine · Woodland Park, CO $184 3% · 3 payments
  4. Terry Sherraden Tallahassee, FL $149 3% · 2 payments
  5. Norman Lepor Beverly Hills, CA $131 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Internal Medicine $1,602 29% · 18 practitioners
  2. Family Medicine $1,236 22% · 23 practitioners
  3. Endocrinology, Diabetes & Metabolism Internal Medicine $1,035 18% · 17 practitioners
  4. Cardiovascular Disease Internal Medicine $934 17% · 24 practitioners
  5. Interventional Cardiology Internal Medicine $208 4% · 6 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Florida $1,145 19% · 15 recipients
  2. Maryland $761 13% · 12 recipients
  3. Pennsylvania $607 10% · 9 recipients
  4. Iowa $601 10% · 8 recipients
  5. Illinois $483 8% · 6 recipients

The top 5 of 25 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

123 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record